Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 263

1.

A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.

Tiringer K, Treis A, Fucik P, Gona M, Gruber S, Renner S, Dehlink E, Nachbaur E, Horak F, Jaksch P, Döring G, Crameri R, Jung A, Rochat MK, Hörmann M, Spittler A, Klepetko W, Akdis CA, Szépfalusi Z, Frischer T, Eiwegger T.

Am J Respir Crit Care Med. 2013 Mar 15;187(6):621-9. doi: 10.1164/rccm.201206-1150OC. Epub 2013 Jan 10.

PMID:
23306544
2.

Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.

Hartl D, Griese M, Kappler M, Zissel G, Reinhardt D, Rebhan C, Schendel DJ, Krauss-Etschmann S.

J Allergy Clin Immunol. 2006 Jan;117(1):204-11. Epub 2005 Nov 28.

PMID:
16387607
3.

Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-γ-treated macrophages to Pseudomonas aeruginosa infection.

Singh S, Barr H, Liu YC, Robins A, Heeb S, Williams P, Fogarty A, Cámara M, Martínez-Pomares L.

PLoS One. 2015 Feb 23;10(2):e0117447. doi: 10.1371/journal.pone.0117447. eCollection 2015.

4.

Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.

Chen AC, Martin ML, Lourie R, Rogers GB, Burr LD, Hasnain SZ, Bowler SD, McGuckin MA, Serisier DJ.

PLoS One. 2015 Mar 30;10(3):e0119325. doi: 10.1371/journal.pone.0119325. eCollection 2015.

5.

Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.

Moser C, Jensen PØ, Pressler T, Frederiksen B, Lanng S, Kharazmi A, Koch C, Høiby N.

APMIS. 2005 Jun;113(6):400-9.

PMID:
15996157
6.

Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Hartl D, Latzin P, Zissel G, Krane M, Krauss-Etschmann S, Griese M.

Am J Respir Crit Care Med. 2006 Jun 15;173(12):1370-6. Epub 2006 Mar 16.

PMID:
16543550
7.

High peripheral blood th17 percent associated with poor lung function in cystic fibrosis.

Mulcahy EM, Hudson JB, Beggs SA, Reid DW, Roddam LF, Cooley MA.

PLoS One. 2015 Mar 24;10(3):e0120912. doi: 10.1371/journal.pone.0120912. eCollection 2015.

8.

The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type.

Moser C, Kjaergaard S, Pressler T, Kharazmi A, Koch C, Høiby N.

APMIS. 2000 May;108(5):329-35.

PMID:
10937769
9.

Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.

Wang Y, Cela E, Gagnon S, Sweezey NB.

Respir Res. 2010 Nov 30;11:166. doi: 10.1186/1465-9921-11-166.

10.

Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection.

Hector A, Schäfer H, Pöschel S, Fischer A, Fritzsching B, Ralhan A, Carevic M, Öz H, Zundel S, Hogardt M, Bakele M, Rieber N, Riethmueller J, Graepler-Mainka U, Stahl M, Bender A, Frick JS, Mall M, Hartl D.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):914-23. doi: 10.1164/rccm.201407-1381OC.

PMID:
25632992
11.

Inflammatory cytokines in cystic fibrosis lungs.

Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M.

Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2111-8. Erratum in: Am J Respir Crit Care Med 1996 Oct;154(4 Pt 1):following 1217.

PMID:
8520783
12.

Differential cytokine profile in children with cystic fibrosis.

Brazova J, Sediva A, Pospisilova D, Vavrova V, Pohunek P, Macek M Jr, Bartunkova J, Lauschmann H.

Clin Immunol. 2005 May;115(2):210-5.

PMID:
15885645
13.

Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients.

Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, Dupont LJ.

Respir Res. 2010 Dec 10;11:177. doi: 10.1186/1465-9921-11-177.

14.

Cytokines in nasal lavages and plasma and their correlation with clinical parameters in cystic fibrosis.

Paats MS, Bergen IM, Bakker M, Hoek RA, Nietzman-Lammering KJ, Hoogsteden HC, Hendriks RW, van der Eerden MM.

J Cyst Fibros. 2013 Dec;12(6):623-9. doi: 10.1016/j.jcf.2013.05.002. Epub 2013 Jun 14.

15.

Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients.

Muhlebach MS, Stewart PW, Leigh MW, Noah TL.

Am J Respir Crit Care Med. 1999 Jul;160(1):186-91.

PMID:
10390398
16.

Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index.

Belessis Y, Dixon B, Hawkins G, Pereira J, Peat J, MacDonald R, Field P, Numa A, Morton J, Lui K, Jaffe A.

Am J Respir Crit Care Med. 2012 Apr 15;185(8):862-73. doi: 10.1164/rccm.201109-1631OC. Epub 2012 Feb 9.

PMID:
22323305
17.

IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis.

Derycke L, Zhang N, Holtappels G, Dutré T, Bachert C.

J Cyst Fibros. 2012 May;11(3):193-200. doi: 10.1016/j.jcf.2011.11.007. Epub 2011 Dec 16.

18.

Regulatory T cell activity is partly inhibited in a mouse model of chronic Pseudomonas aeruginosa lung infection.

Ding FM, Zhu SL, Shen C, Ji XL, Zhou X.

Exp Lung Res. 2015 Feb;41(1):44-55. doi: 10.3109/01902148.2014.964351. Epub 2014 Nov 14.

PMID:
25398094
19.

Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.

Griffin PE, Roddam LF, Belessis YC, Strachan R, Beggs S, Jaffe A, Cooley MA.

PLoS One. 2012;7(7):e42241. doi: 10.1371/journal.pone.0042241. Epub 2012 Jul 31.

20.

T-cell immunotherapy in cystic fibrosis: weighing the risk/reward.

Robinson KM, Alcorn JF.

Am J Respir Crit Care Med. 2013 Mar 15;187(6):564-6. doi: 10.1164/rccm.201212-2201ED. No abstract available.

PMID:
23504359

Supplemental Content

Support Center